<DOC>
	<DOCNO>NCT00166413</DOCNO>
	<brief_summary>Patients primary systemic amyloidosis treat CC-5013 ( lenalidomide ; Revlimid ) single agent 3 month . If disease worsen improve time frame dexamethasone add treatment program .</brief_summary>
	<brief_title>Efficacy CC-5013 ( Revlimid Lenalidomide ) Patients With Primary Systemic Amyloidosis</brief_title>
	<detailed_description />
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>1 . Histochemical diagnosis amyloidosis base detection polarize microscopy green birefringent material Congo redstained tissue specimen immunohistochemical proof AL 2 . Measurable disease AL amyloidosis define one following : Serum monoclonal protein &gt; =1.0 g protein electrophoresis &gt; 200 mg monoclonal protein urine 24 hour electrophoresis Serum immunoglobulin free light chain &amp; &gt; =10 mg/dL AND abnormal serum immunoglobulin kappa lambda free light chain ratio 3 . ECOG performance status ( PS ) 0 , 1 , 2 , 3 4 . &gt; =18 year age 5 . The following laboratory value obtain &lt; =14 day prior registration : Creatinine &lt; = 3 mg/dL Absolute neutrophil count &gt; =1000/microliter Platelet &gt; =75000/microliter Hemoglobin &gt; = 8.0 g/dL 6 . Symptomatic organ involvement amyloid justify therapy . This could include liver involvement , cardiac involvement , renal involvement , peripheral neuropathy grade 1 , soft tissue involvement . Must purpura carpal tunnel syndrome 7 . Previously treat untreated . No limit prior therapy provide adequate residual organ function 8 . Ability provide inform consent 9 . Anticipated life expectancy least 3 month 10 . None follow : Pregnant woman woman reproductive ability unwilling use effective contraception Nursing woman Men unwilling use condom ( even undergone prior vasectomy ) intercourse woman , take drug 4 week stop treatment Myelosuppressive chemotherapy &lt; 4 week prior registration Concomitant high dose corticosteroid Grade 2 ( high ) peripheral neuropathy Uncontrolled infection Clinically overt multiple myeloma Active malignancy Prior hypersensitivity reaction Thalidomide Syncope within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>